Wade Sessions, MD
Orthopaedic Surgery · West Jordan, UTNPI 1659483816
Payments from drug & device makers
Across 119 payments — averaging $107.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Active Medical, LLC$6K
- Stryker$4K
- Arthrex$2K
- Orthalign Inc$245
- Zimmer Biomet$186
- Lima USA, Inc.$178
- plus $694 from 12 others
What the payments were for
- Travel & lodging$3,50327%
- Food & beverage$4,75037%
- Education$4,49235%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Active Medical, LLC | 12 | $6,152 |
| Stryker | 53 | $3,538 |
| Arthrex | 20 | $1,751 |
| Orthalign Inc | 2 | $245 |
| Zimmer Biomet | 2 | $186 |
| Lima USA, Inc. | 3 | $178 |
| Smith+Nephew | 3 | $178 |
| Johnson & Johnson | 4 | $140 |
| Merck | 5 | $97 |
| Boston Scientific | 3 | $66 |
| Ferring Pharmaceuticals Inc. | 3 | $43 |
| Haemonetics Corporation | 2 | $40 |
| Anika Therapeutics, Inc. | 2 | $38 |
| Biocomposites Inc | 1 | $34 |
| Vertex | 1 | $17 |
| Radius Health, Inc. | 1 | $15 |
| Amgen | 1 | $15 |
| Davol Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$1,847
- ICONIX$277
- REELX STT$147
- SMR$139
- Master SL$139
- Physica$139
- H-Max$139
- Legion Revision$126
- REDAPT Revision Hip System$126
- OrthAlign Plus System$125
- ORTHALIGN PLUS$120
- Persona$119
How this compares
$12,745 in reported general payments places this provider in the 65th percentile of 221 orthopaedic surgery providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 57 | $1,869 |
| Naproxen | 14 | $613 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 30 | $420 |
| Oxycodone Hcl | 32 | $239 |
| Ibuprofen | 12 | $214 |
| Ondansetron OdtOndansetron | 14 | $176 |
| Ondansetron Hcl | 33 | $160 |
| Methylprednisolone | 14 | $95 |
| Tramadol Hcl | 25 | $87 |
| Amoxicillin | 27 | $22 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in West Jordan
- Armen KhachatryanWest Jordan$3.9M
- Kevin SagersWest Jordan$30K
- Hugh WestMurray$14.2M
- Aaron HofmannSalt Lake City$10.7M
- Thomas CaltonWashington Terrace$3.5M
- Jeremy GilillandSalt Lake City$3.3M
- Robert TashjianSalt Lake City$3M
- Joshua HickmanBountiful$2.7M
- Jeffrey JacksonSalt Lake City$2.3M
- Peter StevensSlc$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.